7.32 (-%)
As of Nov 01, 2024
Source:
Aurinia Pharmaceuticals Inc. is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by autoimmune, kidney and rare diseases with a high unmet medical need.
| Country | United States |
| Headquarters | edmonton |
| Phone Number | 250-744-2487 |
| Industry | manufacturing |
| CEO | Peter Greenleaf |
| Website | www.auriniapharma.com |